title: Does in-hospital ventricular fibrillation affect prognosis after myocardial infarction?
abstract: OBJECTIVE
  The aim of this study was to estimate the prognostic information to be gained from ventricular fibrillation in patients with myocardial infarction.
  
  
  RESULTS
  We studied 4259 consecutive patients with myocardial infarction admitted to one centre in 1977-1988. Five hundred and twenty-eight (12.4%) of the patients had ventricular fibrillation in hospital. The following risk factors were included in multivariate models to estimate their importance for 30-day and long-term (median 7 year) prognosis: age, gender, ventricular fibrillation, congestive heart failure, pulmonary oedema, cardiogenic shock, other cardiac arrest and atrial fibrillation. We found that the odds ratio for death on days 6.30 was 6.34 (3.55-11.30, 95% confidence limits, P < 0.001) for patients with primary ventricular fibrillation (without heart failure) and 4.06 (2.68-6.14, P < 0.001) for patients with ventricular fibrillation secondary to heart failure compared to patients without ventricular fibrillation. For patients surviving more than 30 days, relative risk of death in those with ventricular fibrillation was 1.11 (95% confidence interval 0.93-1.34, P = 0.26). Logistic regression analysis of relative risk associated with ventricular fibrillation in time intervals, indicated that the importance of ventricular fibrillation for risk of death was exhausted during the initial 60 days after infarction.
  
  
  CONCLUSIONS
  Ventricular fibrillation is associated with an independent increased risk of death within 0-60 days after infarction. After this period, the prognosis in survivors of ventricular fibrillation does not differ significantly from patients without ventricular fibrillation.
authors.affiliation: Department of Cardiology C 40, Glostrup University Hospital, Copenhagen, Denmark.
authors.forename: G V
authors.initials: GV
authors.lastname: Jensen
authors.forename: C
authors.initials: C
authors.lastname: Torp-Pedersen
authors.forename: P
authors.initials: P
authors.lastname: Hildebrandt
authors.forename: L
authors.initials: L
authors.lastname: Kober
authors.forename: F E
authors.initials: FE
authors.lastname: Nielsen
authors.forename: T
authors.initials: T
authors.lastname: Melchior
authors.forename: T
authors.initials: T
authors.lastname: Joen
authors.forename: P K
authors.initials: PK
authors.lastname: Andersen
mesh_terms: D000328:Adult; D017677:Age Distribution; D000368:Aged; D000369:Aged, 80 and over; D000704:Analysis of Variance; D002423:Cause of Death; D016001:Confidence Intervals; D003718:Denmark / Q000453:epidemiology; D005260:Female; D006801:Humans; D007362:Intensive Care Units; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D009203:Myocardial Infarction / Q000150:complications* / Q000401:mortality*; D016016:Proportional Hazards Models; D011446:Prospective Studies; D012307:Risk Factors; D017678:Sex Distribution; D016019:Survival Analysis; D015996:Survival Rate; D014693:Ventricular Fibrillation / Q000150:complications* / Q000401:mortality*